Searched over 200M research papers
10 papers analyzed
These studies suggest metoprolol effectively reduces blood pressure in hypertensive patients, with varying effects depending on individual factors and dosage.
20 papers analyzed
Metoprolol, a selective beta-adrenergic receptor blocker, is widely used in the management of hypertension. This article synthesizes findings from multiple studies to provide a clear understanding of how much metoprolol can lower blood pressure.
A clinical trial evaluated the efficacy of extended-release metoprolol succinate (ER metoprolol) in children aged 6 to 16 years with hypertension. The study found that ER metoprolol significantly reduced systolic blood pressure (SBP) by 7.7 mmHg and diastolic blood pressure (DBP) by 4.9 mmHg at a dose of 1.0 mg/kg, and by 6.3 mmHg and 7.5 mmHg respectively at a dose of 2.0 mg/kg, compared to placebo.
In adults with essential hypertension, metoprolol administered at 25 mg three times daily initially, and then 100 mg three times daily, resulted in a mean decrease in blood pressure of 24/10 mmHg in the lying position and 23/19 mmHg in the standing position. Another study comparing controlled-release metoprolol (50 mg once daily) with conventional metoprolol (50 mg twice daily) found both regimens to be equally effective, reducing blood pressure by approximately 16.8/11.0 mmHg and 16.2/11.2 mmHg respectively.
A long-term study involving 703 hypertensive patients demonstrated that metoprolol, either alone or in combination with a diuretic, significantly reduced both systolic and diastolic blood pressure. The majority of patients achieved a diastolic blood pressure of 90 mmHg or lower within 12 weeks . Another study confirmed that metoprolol at doses ranging from 100 mg to 400 mg daily effectively reduced blood pressure and was well tolerated.
A study comparing metoprolol with bisoprolol found that while both drugs effectively reduced blood pressure, bisoprolol had a more sustained effect over a 24-hour period. This suggests that while metoprolol is effective, other beta blockers may offer longer-lasting blood pressure control.
Research on the combination of metoprolol with taurine in hypertensive rats showed a synergistic effect, with a 22% reduction in mean arterial pressure. This combination also improved endothelial function and reduced oxidative stress, indicating potential benefits beyond blood pressure reduction alone.
Metoprolol is a highly effective beta blocker for reducing blood pressure in both children and adults with hypertension. It can lower systolic blood pressure by up to 24 mmHg and diastolic blood pressure by up to 19 mmHg, depending on the dosage and patient population. While it is effective as a monotherapy, combining metoprolol with other agents like taurine may offer additional benefits. Overall, metoprolol is a well-tolerated and potent option for managing hypertension.
Most relevant research papers on this topic